Zn(2+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Findingreplicated ×5“Compared to non-users, post-diagnosis zinc supplement use was associated with a suggestively lower risk of lethal prostate cancer (HR [95% CI], 0.82 [0.60–1.13]) and significantly lower all-cause mortality (0.84 [0.74–0.96]).”
Quoted verbatim from Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.. - Study
- cohort
- Dose
- any post-diagnostic zinc supplement use (self-reported; dose categories <25 to >=101 mg/day)
- Population
- Men with nonmetastatic prostate cancer in the Health Professionals Follow-up Study (5,788 men; 851 reported post-diagnosis zinc supplement use), compared with non-users; median follow-up 11 years
Effect 0.84 hazard ratio, 95% CI 0.74 to 0.96
Post-diagnostic Zinc Supplement Use and Prostate Cancer Survival Among Men With Nonmetastatic Prostate Cancer.2023PMID:36453265Permalink
Keep reading
- Everything the graph holds on Zn(2+)
- Every compound studied against All-cause mortality
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M5MDZ31R76H6DP6M0WYTDT0S